Fintel reports that on December 9, 2025, Citigroup maintained coverage of Structure Therapeutics Inc. - Depositary Receipt (NasdaqGM:GPCR) with a Buy recommendation. As of December 6, 2025, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback